Date Speaker(s) Presentation Title
Apr 25, 2017

Judith Prochaska, PhD, MPH
Stanford Medicine - Stanford University

Digital Tools for Cancer Prevention: Extending Reach and Engagement

Apr 18, 2017

Steven D. Pearson, MD, MSc, FRCP
Founder and President, Institute for Clinical Economic Review (ICER), Boston, MA

If Medicare Were to Negotiate Drug Prices, How Would it Determine a ‘Fair’ Price for a Cancer Treatment?

Mar 28, 2017

Angela Fagerlin, PhD
Professor & Chair, Department of Population Health Sciences, University of Utah

The Impact of Shared Decision-making Interventions on Prostate Cancer Treatment Decision-making

Mar 21, 2017

Julie R. Palmer, ScD
Boston University

Type 2 Diabetes in Relation to Breast Cancer Risk: Results from the Black Women’s Health Study

Mar 07, 2017

Kate Sweeny, PhD
University of California, Riverside Riverside, CA

The Psychological Impact of Awaiting Breast Diagnosis: A Preliminary Picture

Feb 14, 2017

Betty Ferrell, PhD, MA, FAAN, FPCN
Beckman Research Institute of City of Hope

The Integration of Palliative Care into Standard Oncology Care

Jan 31, 2017

Jim Evans, MD, PhD
The University of North Carolina at Chapel Hill

Cancer Prevention, Genomics, and the PMI

Jan 24, 2017

Andrew Briggs, DPhil, MSc
University of Glasgow

Designing a value framework for oncology: what are the issues with existing frameworks and can we do better?

Jan 17, 2017

Shiriki K. Kumanyika, PhD, MPH
University of Pennsylvania

Obesity, Cancer Prevention, and Health Equity. The Promise of Public Health Approaches

Jan 10, 2017

Victoria L. Champion, PhD, RN, FAAN
Indiana University Simon Cancer Center

How do I develop a program of Cancer Control Science that will make a difference?

Dec 13, 2016

Sudhir Srivastava, PhD, MPH, MS
NCI Division of Cancer Prevention

My Journey to Cancer Biomarker Research: Building a Translational Science Infrastructure - It Takes a Village

Nov 15, 2016

Valerie M. Weaver, PhD
University of California San Francisco

Force and Breast Cancer Risk

Oct 26, 2016

Susan E. Olivo-Marston, PhD, MPH
The Ohio State University

Obesity and Colon Cancer…Does Timing Matter?”

Oct 25, 2016

Erin Kent, PhD, MS
National Cancer Institute

Moving from Patient- to Family-Centric: Progress and Remaining Challenges in Cancer CaregivingMoving from Patient- to Family-Centric: Progress and Remaining Challenges in Cancer Caregiving

Oct 18, 2016

Alan G. Nyitray, PhD
National Cancer Institute

The Epidemiology of Anal HPV in High Risk Men and Novel Opportunities for Anal Cancer Screening

Sep 27, 2016

Elizabeth A. Platz, ScD, MPH
John Hopkins Bloomberg School of Public Health

Enhancing the Infrastructure of a Cardiovascular Disease Cohort for Cancer Edpidemiology Research: Efforts, Findings, and Opportunities

Jun 07, 2016

Douglas L. Weed, MD, PhD, MPH
DLW Consulting Services, LLC

After the NCI: Methods, Mountains, and Mischief

May 31, 2016

Sarah Gehlert, PhD
Washington University in St. Louis

The Effect of Social Influences on African-American Breast Cancer Patients

May 17, 2016

Melinda L. Irwin, PhD, MPH
Yale School of Medicine

Energy Balance Interventions: The New Adjuvant Therapy

May 03, 2016

Nancy Krieger, PhD
Boston University

Segregation, Jim Crow, Racism, Embodied History & the People’s Health: Implications for Cancer Registries, Research & Prevention

Apr 19, 2016

Ulrike Boehmer, PhD
Boston University

Cancer and the LGBT Community: Reporting on an Understudied Population

Apr 05, 2016

Sandro Galea, MD, MPH, DrPH
Boston University

The Principles of Population Health Science: Implications for Cancer Prevention

Mar 29, 2016

Stephen Barnes, PhD
University of Alabama at Birmingham

Understanding Diet Factors That Affect Cancer Risk

Mar 22, 2016

Frank J. Penedo, PhD
Northwestern University

Enhancing Standards of Cancer Care by Capturing Patient Experiences in Academic and Community Settings

Mar 08, 2016

Kurt M. Ribisl, PhD
UNCCH Gillings School of Global Public Health

Tobacco-related Disparities at Point of Sale and Promising Policy Solutions

Feb 23, 2016

John F. McDonald, PhD
Georgia Institute of Technology

An Integrated Approach to Ovarian Cancer Diagnostics and Personalized Therapy

Feb 09, 2016

Susan T. Mayne, PhD, FACE
Center for Food Safety and Applied Nutrition, FDA

FDA's Role in Translating Science for Improved Public Health/Cancer Prevention

Jan 19, 2016

Melissa Troester, PhD, MPH
UNCCH Gillings School of Global Public Health

Landscape of Normal Breast and Breast Cancer

Dec 15, 2015

Norma Fox Kanarek, PhD, MPH
Johns Hopkins School of Public Health

State Cancer Plans, Cancer Centers and Population Health: Tools or Toolbox?

Dec 01, 2015

Corinne Husten, MD, MPH
FDA

The FDA Center for Tobacco Products: Its Role in Reducing Tobacco Use and How Regulatory Science Informs Action